UNSPSC 85892648: Low dose rate (ldr) brachytherapy of chest wall using other isotope

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of low dose rate (ldr) brachytherapy of chest wall using other isotope. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DB17BYZ

UNSPSC 85892648 Low dose rate brachytherapy of chest wall using other isotope is a Commodity code with a material mismatch between its nominal scope and recent state and local procurement activity. The code's title references a specialized cancer treatment modality — low-dose-rate brachytherapy (radiation therapy) targeting chest-wall tumors — yet the single recent opportunity in the record shows no radiation oncology work. Instead, the County of Santa Clara Health System posted a solicitation for temporary health professional staffing services across thirteen ancillary clinical disciplines, including audiology, cardiology, diagnostic imaging, gastroenterology, respiratory care, sterile processing, and therapy services. This staffing solicitation does not align with brachytherapy procurement, indicating either a coding mismatch in the state and local opportunity database or a code under which this jurisdiction rarely posts relevant work.

The source provides no evidence of active state and local procurement under this code for its intended clinical scope. No issuing bodies beyond Santa Clara County appear in the record, no geographic spread is discernible, and no brachytherapy-related opportunities are present. The single posted opportunity — County of Santa Clara Health System's RFQ for temporary clinical staffing due October 7, 2026 — is unrelated to the code's medical physics and oncology focus. Until the recent-opportunities record reflects actual brachytherapy solicitations from state or local health systems, transit authorities, or other agencies, this code signals minimal relevant activity for firms pursuing state and local radiation oncology contracts.